Skip to main content

Advancements in Aggressive Non-Hodgkin Lymphomas (NHL)

November 19, 2024

Replay will be available soon.

 

Topics Covered

We invite you to learn more about:

  • How your NHL subtype determines treatment goals and strategies
  • Current and emerging therapies for aggressive subtypes of NHL
  • Methods to manage side effects
  • The importance of discussing quality-of-life issues with your healthcare team

Program Materials

Transcript will be available soon.

Speaker

Joshua Brody, MD
Director, Lymphoma Immunotherapy Program
Icahn School of Medicine at Mount Sinai 
Hess Center for Science and Medicine 
New York, NY 

Program Support

Support for this program provided by Genentech, a member of the Roche Group.

 

< Back to Webcasts